2248 related articles for article (PubMed ID: 7635564)
1. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry.
Rieger E; Soyer HP; Garbe C; Büttner P; Kofler R; Weiss J; Stocker U; Krüger S; Roser M; Weckbecker J
Int J Cancer; 1995 Aug; 62(4):393-7. PubMed ID: 7635564
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
[TBL] [Abstract][Full Text] [Related]
3. Body-site distribution of melanocytic nevi in young Australian children.
Harrison SL; Buettner PG; MacLennan R
Arch Dermatol; 1999 Jan; 135(1):47-52. PubMed ID: 9923780
[TBL] [Abstract][Full Text] [Related]
4. Site-specific determinants of cutaneous melanoma: a case-case comparison of patients with tumors arising on the head or trunk.
Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2222-31. PubMed ID: 24083994
[TBL] [Abstract][Full Text] [Related]
5. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
Randi G; Naldi L; Gallus S; Di Landro A; La Vecchia C;
J Invest Dermatol; 2006 Sep; 126(9):2106-10. PubMed ID: 16645584
[TBL] [Abstract][Full Text] [Related]
6. [The number and distribution of nevus cell nevi in patients with malignant melanoma].
Welkovich B; Landthaler M; Schmoeckel C; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):630-5. PubMed ID: 2613517
[TBL] [Abstract][Full Text] [Related]
7. Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician.
Lawson DD; Moore DH; Schneider JS; Sagebiel RW
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):438-44. PubMed ID: 8077469
[TBL] [Abstract][Full Text] [Related]
8. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.
Olsen CM; Zens MS; Stukel TA; Sacerdote C; Chang YM; Armstrong BK; Bataille V; Berwick M; Elwood JM; Holly EA; Kirkpatrick C; Mack T; Bishop JN; Østerlind A; Swerdlow AJ; Zanetti R; Green AC; Karagas MR; Whiteman DC
Int J Cancer; 2009 Feb; 124(4):937-44. PubMed ID: 19035450
[TBL] [Abstract][Full Text] [Related]
9. Prediction of high naevus count in a healthy U.K. population to estimate melanoma risk.
Ribero S; Zugna D; Osella-Abate S; Glass D; Nathan P; Spector T; Bataille V
Br J Dermatol; 2016 Feb; 174(2):312-8. PubMed ID: 26479165
[TBL] [Abstract][Full Text] [Related]
10. Dermoscopic naevus patterns in people at high versus moderate/low melanoma risk in Queensland.
Douglas NC; Borgovan T; Carroll MJ; Williams PF; Berry EG; Siskind V; Hoedl AF; Wurm EM; Smithers BM; Green AC; Soyer HP
Australas J Dermatol; 2011 Nov; 52(4):248-53. PubMed ID: 22070697
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Büttner P; Weiss J; Soyer HP; Stocker U; Krüger S; Roser M; Weckbecker J; Panizzon R; Bahmer F
J Invest Dermatol; 1994 May; 102(5):695-9. PubMed ID: 8176250
[TBL] [Abstract][Full Text] [Related]
12. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women.
Weinstock MA; Colditz GA; Willett WC; Stampfer MJ; Bronstein BR; Mihm MC; Speizer FE
J Natl Cancer Inst; 1989 Jun; 81(12):948-52. PubMed ID: 2733040
[TBL] [Abstract][Full Text] [Related]
13. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
14. Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease.
Bain C; Colditz GA; Willett WC; Stampfer MJ; Green A; Bronstein BR; Mihm MC; Rosner B; Hennekens CH; Speizer FE
Am J Epidemiol; 1988 Apr; 127(4):703-12. PubMed ID: 3354537
[TBL] [Abstract][Full Text] [Related]
15. Similar anatomical distributions of childhood naevi and cutaneous melanoma in young adults residing in northern and southern Sweden.
Karlsson MA; Rodvall Y; Wahlgren CF; Wiklund K; Lindelöf B
Eur J Cancer; 2015 Sep; 51(14):2067-75. PubMed ID: 26187511
[TBL] [Abstract][Full Text] [Related]
16. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body.
Fariñas-Alvarez C; Ródenas JM; Herranz MT; Delgado-Rodríguez M
Br J Dermatol; 1999 Mar; 140(3):457-62. PubMed ID: 10233266
[TBL] [Abstract][Full Text] [Related]
17. [Rare melanocytes and nevus-cell nevi].
Frenk E; Mevorah B; Delacrétaz J
Hautarzt; 1975 Dec; 26(12):619-24. PubMed ID: 1213881
[TBL] [Abstract][Full Text] [Related]
18. Nevi and Breslow thickness in melanoma: sex differences?
De Giorgi V; Scarfì F; Gori A; Maida P; Trane L; Silvestri F; Portelli F; Massi D; Covarelli P; Gandini S
Melanoma Res; 2020 Apr; 30(2):179-184. PubMed ID: 31574530
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
Barnhill RL
Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
[TBL] [Abstract][Full Text] [Related]
20. Problems of melanoma developing from common acquired nevi.
Paul E
Pediatr Pol; 1986 Aug; 61(8):491-9. PubMed ID: 3574997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
